Tabula Rasa HealthCare Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Tabula Rasa HealthCare current Real Value cannot be determined due to lack of data. The regular price of Tabula Rasa HealthCare is $0.0. Our model measures the value of Tabula Rasa HealthCare from inspecting the company fundamentals such as Shares Outstanding of 27.05 M, operating margin of (0.06) %, and Return On Equity of -5.55 as well as reviewing its technical indicators and probability of bankruptcy.
Tabula Rasa Total Value Analysis
Tabula Rasa HealthCare is at this time forecasted to have valuation of 548.09 M with market capitalization of 284.03 M, debt of 336.13 M, and cash on hands of 26.52 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tabula Rasa fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
548.09 M | 284.03 M | 336.13 M | 26.52 M |
Tabula Rasa Investor Information
About 12.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.46. Tabula Rasa HealthCare had not issued any dividends in recent years. Based on the key measurements obtained from Tabula Rasa's financial statements, Tabula Rasa HealthCare is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Tabula Rasa Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tabula Rasa has an asset utilization ratio of 77.97 percent. This indicates that the Company is making $0.78 for each dollar of assets. An increasing asset utilization means that Tabula Rasa HealthCare is more efficient with each dollar of assets it utilizes for everyday operations.Tabula Rasa Ownership Allocation
Tabula Rasa HealthCare shows a total of 27.05 Million outstanding shares. The majority of Tabula Rasa HealthCare outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Tabula Rasa to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Tabula Rasa HealthCare. Please pay attention to any change in the institutional holdings of Tabula Rasa HealthCare as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Tabula Rasa Profitability Analysis
The company reported the previous year's revenue of 299.52 M. Net Loss for the year was (147.51 M) with profit before overhead, payroll, taxes, and interest of 66.91 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Tabula Rasa's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Tabula Rasa and how it compares across the competition.
Tabula Rasa Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 24.3 M | |
Forward Price Earnings | 217.3913 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Tabula Stock
If you are still planning to invest in Tabula Rasa HealthCare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tabula Rasa's history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |